Investigating the cell permeability of proteolysis-targeting chimeras (PROTACs)

被引：13
|
作者：
Yokoo, Hidetomo [1 ,2 ]
Naito, Mikihiko [1 ,3 ,6 ]
Demizu, Yosuke [1 ,4 ,5 ,7 ]
机构：
[1] Natl Inst Hlth Sci, Div Organ Chem, Kawasaki, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Med Chem, Kyoto, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo, Japan
[4] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Japan
[5] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita, Japan
[6] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo 1130033, Japan
[7] Natl Inst Hlth Sci, Div Organ Chem, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan
来源：
EXPERT OPINION ON DRUG DISCOVERY | 2023年 / 18卷 / 04期
基金：
日本学术振兴会;
关键词：
Cell permeability; cell-penetrating peptide; molecular weight; nanoparticle; prodrug; PROTAC; SOLUBILITY; MOLECULES; DESIGN;
D O I：
10.1080/17460441.2023.2187047
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：357 / 361
页数：5
相关论文
共 50 条
  • [21] BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?
    Cruz-Rodriguez, Nataly
    Tang, Hua
    Bateman, Benjamin
    Tang, Weiping
    Deininger, Michael
    LEUKEMIA, 2024, 38 (09) : 1885 - 1893
  • [22] Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
    Burslem, George M.
    Crews, Craig M.
    CELL, 2020, 181 (01) : 102 - 114
  • [23] Proteolysis-targeting chimeras: a kaleidoscope of targeted protein degradation
    Mou, Yi
    Wen, Shuai
    Gao, Xinxing
    Jiang, Zheng-Yu
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (03) : 139 - 141
  • [24] Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
    Jin, Yerim
    Lee, Yeongju
    CHEMMEDCHEM, 2024, 19 (23)
  • [25] In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs)
    Tomoshige, Shusuke
    Ishikawa, Minoru
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 41
  • [26] Developing PROteolysis TArgeting Chimeras (PROTACs) for hematologic malignancies
    Wu, Yangping
    Zhang, Jingliao
    Zhu, Xiaofan
    Zhang, Yingchi
    CANCER LETTERS, 2022, 544
  • [27] Synthetic approaches to constructing proteolysis targeting chimeras (PROTACs)
    Bakulina, Olga
    Sapegin, Alexander
    Bunev, Alexander S.
    Krasavin, Mikhail
    MENDELEEV COMMUNICATIONS, 2022, 32 (04) : 419 - 432
  • [28] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
    Khan, Sajid
    He, Yonghan
    Zhang, Xuan
    Yuan, Yaxia
    Pu, Shaoyan
    Kong, Qingpeng
    Zheng, Guangrong
    Zhou, Daohong
    ONCOGENE, 2020, 39 (26) : 4909 - 4924
  • [29] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
    Sajid Khan
    Yonghan He
    Xuan Zhang
    Yaxia Yuan
    Shaoyan Pu
    Qingpeng Kong
    Guangrong Zheng
    Daohong Zhou
    Oncogene, 2020, 39 : 4909 - 4924
  • [30] Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers
    Liu, Li
    Shi, Lihong
    Wang, Zhaodi
    Zeng, Jun
    Wang, Yue
    Xiao, Hongtao
    Zhu, Yongxia
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345